PharmaShots | Incisive News in 3 Shots

Subscribe Now

full-life technologies

Full-Life Technologies’ 225Ac-FL-020 Gains the US FDA’s Fast Track Designation to Treat Metastatic Castration-Resistant Prostate Cancer

Full-Life Technologies’ 225Ac-FL-020 Gains the US FDA’s Fast Track Designation to Treat Metastatic Castration-Resistant Prostate C...

July 4, 2024

Full-Life Technologies Signed an Agreement to Acquire Focus-X Therapeutics to Advance Peptide-Focused Radiopharmaceutical Pipeline

Full-Life Technologies Signed an Agreement to Acquire Focus-X Therapeutics to Advance Peptide-Focused Radiopharmaceutical Pipeline

November 29, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us